- Home
- TOMZ vs NCNA Comparison
TOMZ vs NCNA Comparison
Compare TOMZ & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TOMZ | NCNA |
|---|---|---|
| Founded | 1979 | 1997 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5M | 8.8M |
| IPO Year | 2009 | 2017 |
Fundamental Metrics
Financial Performance| Metric | TOMZ | NCNA |
|---|---|---|
| Price | $0.64 | $1.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 216.1K | 29.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,738,842.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $68.67 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.23 | N/A |
| 52 Week Low | $0.54 | $0.03 |
| 52 Week High | $1.20 | $10.00 |
Technical Indicators
Market Signals| Indicator | TOMZ | NCNA |
|---|---|---|
| Relative Strength Index (RSI) | 40.89 | 36.81 |
| Support Level | $0.54 | $0.05 |
| Resistance Level | $0.81 | $2.27 |
| Average True Range (ATR) | 0.06 | 0.16 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 45.14 | 18.42 |
Price Performance
Historical ComparisonAbout TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.